Literature DB >> 22426616

National prescribing data for dabigatran.

Scott Metcalfe, Peter Moodie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426616

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


× No keyword cloud information.
  5 in total

1.  Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran.

Authors:  Paul K L Chin; David M Patterson; Mei Zhang; Berit P Jensen; Daniel F B Wright; Murray L Barclay; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

2.  Use of Direct-Acting Oral Anticoagulants in Nonagenarians: A Call for More Data.

Authors:  Claudia Stöllberger; Roman Brooks; Josef Finsterer; Thomas Pachofszky
Journal:  Drugs Aging       Date:  2016-05       Impact factor: 3.923

Review 3.  A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time.

Authors:  Paul K L Chin; Daniel F B Wright; David M Patterson; Matthew P Doogue; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

4.  Age-dependency of prescribing patterns of oral anticoagulant drugs in Austria during 2011-2014.

Authors:  Thomas Schuh; Berthold Reichardt; Josef Finsterer; Claudia Stöllberger
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

5.  Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis.

Authors:  Yan Xu; Anne M Holbrook; Christopher S Simpson; Dar Dowlatshahi; Ana P Johnson
Journal:  CMAJ Open       Date:  2013-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.